Aging Population And Chronic Illnesses Will Expand Post-Acute Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
11 May 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$21.00
42.5% undervalued intrinsic discount08 Aug
US$12.07
1Y
-63.1%7D
-4.0%